Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 544 of 1,261
  1. US 10080379

    Zinc and copper fortifying composition, a hydrating supplement, and process for preparing the same

    Tata Global Beverages Ltd. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  2. US 10080718

    Method of treating ear infections

    Try This First, Inc. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  3. IT 201700031902

    Composizione nutraceutica, dietetica e nutrizionale ad attività antiossidante.

    A MENARINI IND FARMACEUTICHE RIUNITE S R L · Granted Sep 23, 2018 · Expires Sep 18, 2038

    granted
  4. US 2018264111

    PHARMACEUTICAL PRODUCT WITH INCREASED STABILITY COMPRISING IMMUNOGLOBULINS

    CSL BEHRING GMBH AG [CH] · Granted Sep 20, 2018 · Expires Sep 15, 2038

    granted
  5. US 10077296

    Methods and compositions for the treatment and prevention of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  6. US 10076571

    Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  7. US 10076535

    Use of CPG oligonucleotides co-formulated with an antibiotic to accelerate wound healing

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  8. US 10076521

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  9. US 10076513

    Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  10. US 10077273

    SHMT inhibitors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  11. US 10077250

    Antifungal compound process

    Tlie United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  12. US 10077266

    Substituted pyrido[3,4-b]pyrazines as GPR6 modulators

    Takeda Pharmaceutical Company Limited · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  13. US 10076520

    Use of tyrosine kinase inhibitor in cancer treatment

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  14. US 10076527

    Standardized extract and its use in the manufacture of a medicament

    Botanic Century (Beijing) Co. Ltd. · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  15. US 10076532

    Acyclic nucleoside phosphonate diesters

    The Regents of the University of California · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  16. US 10076509

    Nested particles and the use thereof for coordinated delvery of active agents

    The Board of Regents of the University of Texas System · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  17. US 10076505

    Inhalation formulations of Treprostinil

    United Therapeutics Corporation · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  18. US 10076495

    Structures for transdermal drug delivery

    Nemaura Pharma Limited · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  19. US 10077446

    Glucan-encapsulated siRNA for treating type 2 diabetes mellitus

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  20. US 10077236

    Azacyclic constrained analogs of FTY720

    The Regents of the University of California · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  21. US 10077232

    Cyclic cationic lipids and methods of use

    ARBUTUS BIOPHARMA CORPORATION · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  22. US 10076546

    Network-based microbial compositions and methods

    Seres Therapeutics, Inc. · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  23. US 10077271

    Methods and compositions for inhibiting the interaction of menin with MLL proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  24. US 10076562

    Methods for treating plague

    The Board of Regents of the University of Texas System · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.